drugset / Trial / NCT00535587
Testing Mestinon and Exercise in Fibromyalgia
Phase 2
Completed
178 enrolled
Oregon Health and Science University
National Institute of Nursing Research (NINR) · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this trial was to test the combined and independent effects of 6 months of exercise and Mestinon in people with fibromyalgia. Specifically, we wanted to determine if Mestinon helped people with fibromyalgia have an easier time exercising and if their symptoms improved by the end of the trial.
Timeline
- Start
- 2002-09
- Primary completion
- 2008-06
- Completion
- 2008-06
Outcome
Met primary endpoint
registry analysis (superiority or other test); Mestinon/Exercise vs Placebo Pill/Attention Control; p <0.02; Median Difference (Final Values) .05; ANCOVA NCT00535587 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pyridostigmine | Small molecule | — | — |